Kazia Therapeutics Stock Forecast - Naive Prediction
| KZIA Stock | USD 7.51 0.51 7.29% |
The Naive Prediction forecasted value of Kazia Therapeutics Ltd on the next trading day is expected to be 9.82 with a mean absolute deviation of 1.23 and the sum of the absolute errors of 76.53. Kazia Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kazia Therapeutics stock prices and determine the direction of Kazia Therapeutics Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kazia Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of Kazia Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (0.01) | EPS Estimate Next Year (0.01) | Wall Street Target Price 19.4458 | Quarterly Revenue Growth (0.27) |
Using Kazia Therapeutics hype-based prediction, you can estimate the value of Kazia Therapeutics Ltd from the perspective of Kazia Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Kazia Therapeutics Ltd on the next trading day is expected to be 9.82 with a mean absolute deviation of 1.23 and the sum of the absolute errors of 76.53. Kazia Therapeutics after-hype prediction price | USD 9.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Kazia Therapeutics to cross-verify your projections. Kazia Therapeutics Additional Predictive Modules
Most predictive techniques to examine Kazia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kazia using various technical indicators. When you analyze Kazia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kazia Therapeutics Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Kazia Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 1999-06-30 | Previous Quarter 4.3 M | Current Value 4.3 M | Quarterly Volatility 17.3 M |
Kazia Therapeutics Naive Prediction Price Forecast For the 25th of January
Given 90 days horizon, the Naive Prediction forecasted value of Kazia Therapeutics Ltd on the next trading day is expected to be 9.82 with a mean absolute deviation of 1.23, mean absolute percentage error of 2.23, and the sum of the absolute errors of 76.53.Please note that although there have been many attempts to predict Kazia Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kazia Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kazia Therapeutics Stock Forecast Pattern
| Backtest Kazia Therapeutics | Kazia Therapeutics Price Prediction | Buy or Sell Advice |
Kazia Therapeutics Forecasted Value
In the context of forecasting Kazia Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kazia Therapeutics' downside and upside margins for the forecasting period are 0.08 and 22.35, respectively. We have considered Kazia Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kazia Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Kazia Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.7521 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.2344 |
| MAPE | Mean absolute percentage error | 0.1471 |
| SAE | Sum of the absolute errors | 76.5319 |
Predictive Modules for Kazia Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kazia Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kazia Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Kazia Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kazia Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kazia Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kazia Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Kazia Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kazia Therapeutics' historical news coverage. Kazia Therapeutics' after-hype downside and upside margins for the prediction period are 0.45 and 21.55, respectively. We have considered Kazia Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kazia Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of Kazia Therapeutics is based on 3 months time horizon.
Kazia Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kazia Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kazia Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kazia Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.77 | 12.53 | 1.56 | 0.28 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.51 | 9.03 | 20.24 |
|
Kazia Therapeutics Hype Timeline
Kazia Therapeutics is now traded for 7.51. The entity has historical hype elasticity of 1.56, and average elasticity to hype of competition of 0.28. Kazia is forecasted to increase in value after the next headline, with the price projected to jump to 9.03 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 20.24%, whereas the daily expected return is now at 0.77%. The volatility of related hype on Kazia Therapeutics is about 3495.12%, with the expected price after the next announcement by competition of 7.79. Kazia Therapeutics Ltd currently holds 396 K in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Kazia Therapeutics has a current ratio of 1.59, which is within standard range for the sector. Note, when we think about Kazia Therapeutics' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Kazia Therapeutics to cross-verify your projections.Kazia Therapeutics Related Hype Analysis
Having access to credible news sources related to Kazia Therapeutics' direct competition is more important than ever and may enhance your ability to predict Kazia Therapeutics' future price movements. Getting to know how Kazia Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kazia Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CANF | Can Fite Biopharma | 0.02 | 3 per month | 0.00 | (0.16) | 10.40 | (8.59) | 38.42 | |
| CNSP | CNS Pharmaceuticals | 0.02 | 3 per month | 0.00 | (0.12) | 7.22 | (7.57) | 26.44 | |
| SILO | Silo Pharma | (0.02) | 21 per month | 0.00 | (0.13) | 8.33 | (6.98) | 24.79 | |
| SNGX | Soligenix | (0.03) | 9 per month | 0.00 | (0.06) | 7.03 | (6.25) | 30.10 | |
| BDRX | Biodexa Pharmaceticals | 1.55 | 9 per month | 0.00 | (0.04) | 11.45 | (16.09) | 128.35 | |
| CMND | Clearmind Medicine Common | 0.02 | 12 per month | 0.00 | (0.32) | 11.72 | (21.84) | 56.34 | |
| INM | InMed Pharmaceuticals | 0.02 | 15 per month | 0.00 | (0.16) | 7.48 | (9.30) | 30.84 | |
| GRI | GRI Bio | 0.02 | 6 per month | 0.00 | (0.26) | 11.88 | (12.95) | 76.91 | |
| OGEN | Oragenics | (0.03) | 9 per month | 0.00 | (0.17) | 4.55 | (7.53) | 19.90 | |
| TTNP | Titan Pharmaceuticals | 2.03 | 22 per month | 5.38 | 0.04 | 9.38 | (8.08) | 30.41 |
Other Forecasting Options for Kazia Therapeutics
For every potential investor in Kazia, whether a beginner or expert, Kazia Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kazia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kazia. Basic forecasting techniques help filter out the noise by identifying Kazia Therapeutics' price trends.Kazia Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kazia Therapeutics stock to make a market-neutral strategy. Peer analysis of Kazia Therapeutics could also be used in its relative valuation, which is a method of valuing Kazia Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kazia Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Kazia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kazia Therapeutics shares will generate the highest return on investment. By undertsting and applying Kazia Therapeutics stock market strength indicators, traders can identify Kazia Therapeutics Ltd entry and exit signals to maximize returns.
| Accumulation Distribution | 24272.14 | |||
| Daily Balance Of Power | 0.9444 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 7.25 | |||
| Day Typical Price | 7.34 | |||
| Price Action Indicator | 0.51 | |||
| Period Momentum Indicator | 0.51 |
Kazia Therapeutics Risk Indicators
The analysis of Kazia Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kazia Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kazia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.67 | |||
| Semi Deviation | 9.73 | |||
| Standard Deviation | 12.09 | |||
| Variance | 146.14 | |||
| Downside Variance | 111.29 | |||
| Semi Variance | 94.71 | |||
| Expected Short fall | (8.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kazia Therapeutics
The number of cover stories for Kazia Therapeutics depends on current market conditions and Kazia Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kazia Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kazia Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kazia Therapeutics Short Properties
Kazia Therapeutics' future price predictability will typically decrease when Kazia Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kazia Therapeutics Ltd often depends not only on the future outlook of the potential Kazia Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kazia Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 4.3 M |
Check out Historical Fundamental Analysis of Kazia Therapeutics to cross-verify your projections. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kazia Therapeutics. If investors know Kazia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kazia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.72) | Revenue Per Share | Quarterly Revenue Growth (0.27) | Return On Assets | Return On Equity |
The market value of Kazia Therapeutics is measured differently than its book value, which is the value of Kazia that is recorded on the company's balance sheet. Investors also form their own opinion of Kazia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kazia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kazia Therapeutics' market value can be influenced by many factors that don't directly affect Kazia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kazia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kazia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kazia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.